Proteon Therapeutics ^{Priced, Nasdaq: PRTO}

Developing a treatment to reduce failure rates of a dialysis-related procedure.

Industry: Health Care

First Day Return: +0.3%

PRTO

Developing a treatment to reduce failure rates of a dialysis-related procedure.

IPO News for Proteon Therapeutics

US IPO Weekly Recap: With just 3 IPOs, more companies postpone than go public 10/24/14
Proteon Therapeutics prices IPO at $10, below the range 10/21/14
Week Ahead: 5 IPOs planned for the week of October 20 include e-cigarettes and asset management 10/19/14

IPO Data
IPO Date	10/21/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$61
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Waltham, MA, United States
Founded	2001
Employees at IPO	11
Website www.proteontherapeutics.com

IPO News for Proteon Therapeutics

Proteon Therapeutics (PRTO) Performance